GPT and Thrombocytopenia: After 10 months from emapalumab treatment, she presented recurrent episodes of relapsing/remitting fever, rash, thrombocytopenia, increased levels of inflammatory markers, of liver function tests (ALT 1333, AST 851, LDH 822 UI/l) and hyperferritinemia (>1500 ng/ml).